Pediatrix Medical Group, Inc. (MD)
(Real Time Quote from BATS)
$7.30 USD
+0.08 (1.11%)
Updated Jun 28, 2024 10:34 AM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Price, Consensus and EPS Surprise
MD 7.30 +0.08(1.11%)
Will MD be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for MD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MD
Implied Volatility Surging for Pediatrix Medical (MD) Stock Options
Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pediatrix (MD) Q1 Earnings Beat on Hospital Contract Fees
Compared to Estimates, Pediatrix Medical Group (MD) Q1 Earnings: A Look at Key Metrics
Life Time Group Holdings, Inc. (LTH) Q1 Earnings Miss Estimates
Other News for MD
Midland and Probe Gold Resume Work on the Copper-Gold-Silver-Molybdenum Discovery on the La Peltrie Option
Midland and Probe Gold Advance Mining Exploration
Pediatrix Medical Group Restructures, Executive VP Exits
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Catalent (CTLT) and Pediatrix Medical Group (MD)
Pediatrix Medical just upgraded at Deutsche Bank, here's why